Zhang et al. (30) used Mendelian randomization to show that specific gut microbial metabolic pathways are causally linked to breast cancer risk, with part of this effect mediated by immune cell subsets (CD4^+CD8^+ leukocytes) (30). The gene discussed is CD4; the disease is breast cancer.